Eledon Pharmaceuticals Inc (NASDAQ:ELDN) currently has a daily average trading volume of 218.94K but it saw 3159742 shares traded in last market. With a market cap of 166.16M USD, the company’s current market price of $4.19 came rising about 16.71 while comparing to the previous closing price of $3.59. In past 52 weeks, the stock remained buoying in the range of price level as high as $4.12 and as low as $1.07. In the recent trading on the day, stock has struck highest price mark of $3.5 while lowest mark touched by it was $4.41.
Taking a look at 20-day trading activity of Eledon Pharmaceuticals Inc (ELDN) gives us an average price of $3.03, while its current price level is 1.70% below from 52-week high level whereas it is 291.59% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $2.79 while that of 200 days or SMA-200 reads an average of $2.39. A closer look into the stock’s movement over the week reveals that its volatility is standing at 14.61% during that period while stretching the period over a month that decreases to 8.57%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 82.92 which implies that the stock is in overbought territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Cantor Fitzgerald which resumed the stock as “Overweight” in its note to investors issued on May 13, 2022, recommending a price target of between $25 and $15 for it.
Over the week, ELDN’s stock price is moving 20.06% up while it is 71.72% when we observe its performance for the past one month. Year-to-date it is 132.78% up and over the past year, the stock is showing an upside performance of 165.19%.
Currently, Eledon Pharmaceuticals Inc’s total number of outstanding shares is 39.66M. Company’s return on equity (ROE) at -360.26%. Stock’s beta reads 0.88. Its return on asset (ROA) is -144.96% on average.
